Pharmaco-Imagery and Theranostic Agents (Q3694905)

From EU Knowledge Graph
Revision as of 09:13, 13 January 2022 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations)
Jump to navigation Jump to search
Project Q3694905 in France
Language Label Description Also known as
English
Pharmaco-Imagery and Theranostic Agents
Project Q3694905 in France

    Statements

    0 references
    187,989.0 Euro
    0 references
    457,614.57 Euro
    0 references
    41.08 percent
    0 references
    30 March 2015
    0 references
    30 September 2017
    0 references
    Université de Bourgogne
    0 references
    0 references
    Le développement de nouveaux médicaments est un processus de plus en plus coûteux et compliqué sur le plan réglementaire comme technique; l’imagerie médicale dans ce contexte représente un axe stratégique pour l’économie. (French)
    0 references
    The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English)
    22 November 2021
    0 references
    Die Entwicklung neuer Arzneimittel ist in regulatorischer und technischer Hinsicht immer kostspieliger und komplizierter. die medizinische Bildgebung in diesem Zusammenhang stellt einen strategischen Schwerpunkt für die Wirtschaft dar. (German)
    1 December 2021
    0 references
    De ontwikkeling van nieuwe geneesmiddelen is een steeds duurder en technisch ingewikkelder regelgevingsproces; medische beeldvorming in deze context is een strategische focus voor de economie. (Dutch)
    6 December 2021
    0 references
    Lo sviluppo di nuovi farmaci è un processo normativo sempre più costoso e tecnicamente complicato; L'imaging medico in questo contesto è un obiettivo strategico per l'economia. (Italian)
    13 January 2022
    0 references

    Identifiers

    BG0003226
    0 references